Indivior PLC Ordinary Shares (INDV) Balance Sheet
A balance sheet shows what a company owns and owes, and shareholders' equity, at a single point in time.
Indivior Pharmaceuticals, Inc.
Total Assets Chart for Indivior PLC Ordinary Shares
Indivior PLC Ordinary Shares (INDV) total assets for FY2025 were USD 1.2B, a -8.7% change from FY2024. Indivior PLC Ordinary Shares's total assets grew from USD 1.2B in 2016 to USD 1.2B in 2025 (-0.4% over 9 years). Total assets compound annual growth rate: 5-year CAGR of -4.7%.
Total Assets (US Dollars)
R&D as % of Revenue
Compare with
Key Stats
- Market Cap
- $4.07B
- Implied Share Price
- $34.47
- Enterprise Value
- $4.50B
- Revenue (TTM)
- $1.33B
- EBITDA
- $576.00M
- Profit Margin
- 26.75%
- Trailing P/E
- 12.35
- Forward P/E
- 9.37
- Price/Book (MRQ)
- 145.25
- Price/Sales (TTM)
- 3.06
- EV/EBITDA
- 10.27
- EV/Revenue
- 3.38
- Dividend Yield
- —
- Book Value
- $-1.76
- Free Cash Flow (FY2025)
- -$94.00M
- Free Cash Flow Yield
- -2.31%
Snapshot as of 24th October 2026 — not point-in-time controlled, may lag the live market by a few days.